Philips highlights MediReport integration: Philips stock sits 12.48 percent below its high
Published on 10/26/2026 at 10:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMediReport context and dates
- On October 20, 2026, 79 percent of surveyed cardiac professionals said incomplete data cost clinical time.
- Philips reported EUR 4.36 billion in second-quarter 2026 revenue and EUR 384.0 million in net income.
- Philips stock trades at EUR 24.13 at 10:46 a.m. CEST at Lang & Schwarz on October 26, 2026, 0.71 percent above the Xetra close of October 23, 2026.
- Philips will publish third-quarter 2026 results on November 3, 2026.
Philips (ISIN NL0000009538) highlighted MediReport's cardiovascular informatics capabilities on October 20, 2026, ahead of the TCT 2026 medical conference. The company said the acquired reporting technology should support a more connected, AI-enabled and cloud-ready workflow, according to GlobeNewswire.
Cardiology workflow gets a test
The MediReport integration gives Philips a concrete product angle in cardiovascular informatics. Its MediReport 360 platform supports structured documentation and real-time reporting before, during and after procedures, while allowing health systems to reuse information for coding, registries and follow-up, according to GlobeNewswire.
The immediate investor question is execution rather than headline size. The same Philips release cited a Future Health Index survey in which 79 percent of cardiac care professionals reported losing clinical time because patient data was incomplete or inaccessible; almost half of that group lost more than 45 minutes per shift.
Three dates trace the strategy
On February 10, 2026, Philips presented its 2026 to 2028 plan at its Capital Markets Day, as described on Philips. On July 28, 2026, second-quarter revenue reached EUR 4.36 billion and net income EUR 384.0 million, according to Simply Wall St. On October 20, 2026, Philips highlighted MediReport's role in its cardiovascular informatics portfolio, with the release noting that 79 percent of surveyed professionals lost clinical time because of incomplete data.
What is the next reporting date?
Philips will publish third-quarter 2026 results on November 3, 2026, at 7:00 a.m. CET, followed by a conference call at 10:00 a.m. CET, according to Philips. The upcoming report will show whether the second-quarter revenue base of EUR 4.36 billion is holding as the company expands connected care and informatics offerings.
Stock below its yearly high
Philips stock was trading at EUR 24.13 at Lang & Schwarz on October 26, 2026 at 10:46 a.m. CEST, 0.71 percent above the Xetra close of October 23, 2026 (EUR 23.96). The 52-week range was EUR 20.92 to EUR 27.57, putting the current price 12.48 percent below the high.
The further course of trading is shown by the continuously updated real-time quote of Philips stock.
Philips stock facts
- Company: Koninklijke Philips N.V.
- ISIN: NL0000009538
- Ticker: PHIA
- Primary exchange: AEX
- Price Lang & Schwarz (as of October 26, 2026, 10:46 a.m. CEST): EUR 24.13
- Change versus Xetra close: plus 0.71 percent
- Xetra close (October 23, 2026): EUR 23.96
- Market capitalization: EUR 23.6 billion (as of October 26, 2026)
- 52-week range: EUR 20.92-EUR 27.57 (as of October 26, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: AEX
- Next earnings date: November 3, 2026
Market context: Market report AEX.
